Based on the demonstration of high levels of VEGF in BM biopsies from APL patients [15], we first investigated VEGF expression in an APL transgenic mouse (TM) model expressing the PML/RARα fusion gene under the control of human cathepsin gene promoter (hCG) [33, 38]. Here, CTSS is linked to acute promyelocytic leukemia.